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Abstract
Background: To ascertain the population rates and proportion of late entry into HIV care, as well as to determine
whether such late entry correlates with individual and contextual factors.
Methods: Data for the 2003–2006 period in Brazil were obtained from public health records. A case of late entry
into HIV care was defined as one in which HIV infection was diagnosed at death, one in which HIV infection was
diagnosed after the condition of the patient had already been aggravated by AIDS-related diseases, or one in which
the CD4+ T-cell count was≤ 200 cells/mm3 at the time of diagnosis. We also considered extended and stricter sets
of criteria (in which the final criterion was≤ 350 cells/mm3 and≤ 100 cells/mm3, respectively). The estimated risk
ratio was used in assessing the effects of correlates, and the population rates (per 100,000 population) were
calculated on an annual basis.
Results: Records of 115,369 HIV-infected adults were retrieved, and 43.6% (50,358) met the standard criteria for late
entry into care. Diagnosis at death accounted for 29% (14,457) of these cases. Late entry into HIV care (standard
criterion) was associated with certain individual factors (sex, age, and transmission category) and contextual factors
(region with less economic development/increasing incidence of AIDS, lower local HIV testing rate, and smaller
municipal population). Use of the extended criteria increased the proportion of late entry by 34% but did not
substantially alter the correlations analyzed. The overall population rate of late entry was 9.9/100,000 population,
specific rates being highest for individuals in the 30–59 year age bracket, for men, and for individuals living in
regions with greater economic development/higher HIV testing rates, collectively accounting for more than half of
the cases observed.
Conclusions: Although the high proportion of late entry might contribute to spreading the AIDS epidemic in less
developed regions, most cases occurred in large cities, with broader availability of HIV testing, and in economically
developed regions.
Keywords: AIDS, Health policy, Late HIV diagnosis, Risk, Brazil
Background
The effectiveness of AIDS treatment programs is severely
affected by the proportion of HIV-infected individuals
who do not enter into clinical care in a timely manner
(i.e., who enter late). This is because HIV-infected indivi-
duals who are under treatment are less likely to transmit
the virus to others, not only because such individuals
tend to adopt safe sex practices but also because the use
of antiretroviral therapy (ART) can reduce the risk of
sexual transmission of HIV by more than 90% [1,2]. Late
entry into care is also strongly associated with premature
death among HIV-infected individuals [3-7], accounting
for approximately 40% of all AIDS-related deaths [8].
Late entry into HIV care also has negative consequences
for health care systems, increasing costs due to the medi-
cations and highly complex procedures required in order
to treat individuals who are in the advanced stages of
HIV infection when they enter treatment [9,10]. To
minimize this problem, there have been numerous initia-
tives aimed at promoting early diagnosis and the initi-
ation of clinical treatment in the early stages of infection
[11-15], particularly through encouraging voluntary test-
ing [11,13,14] and by strengthening the cooperation
* Correspondence: ale.grangeiro@gmail.com
†Equal contributors
1Departamento de Medicina Preventiva da Faculdade de Medicina da
Universidade de São Paulo, São Paulo, Brazil
Full list of author information is available at the end of the article
© 2012 Grangeiro et al.; licensee BioMed Central Ltd This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Grangeiro et al. BMC Infectious Diseases 2012, 12:99
http://www.biomedcentral.com/1471-2334/12/99
between and among centers for the diagnosis and treat-
ment of HIV-infected individuals [13,14]. Nevertheless,
the proportion of individuals who have sought treatment
late remains high—over 30% in high income countries
[16-23] and over 70% in African countries [9,24]. The
main hindrances to the success of these initiatives are
related to the individual [12,13,25,26], the social context
[25-27], and the way in which the health care services are
organized [19,28-30].
Although differing in their methodological approaches
[31], studies of late entry into HIV care have provided,
for different contexts, a broad range of estimates of the
proportion of such late entry and have identified differ-
ent associated risk factors [16,19-23,32]. Therefore, there
is a need for further knowledge about the absolute risk
of late entry, both at the population level and in social
segments exposed to certain risk factors (such as
advanced age, male gender, and a low level of local eco-
nomic development). In low- and middle-income coun-
tries, the proportion of individuals entering HIV care late
has often been evaluated on the basis of the time at
which ART is initiated, rather than the actual time of
entry into care [24,33,34]. This strategy has two draw-
backs. First, it ignores the fact that other therapeutic and
prophylactic interventions should be undertaken prior to
the initiation of ART. Second, the criterion for starting
ART has changed over time, and there is a trend toward
earlier prescription of ART. Therefore, when late entry
into care is defined by the initiation of ART, it is difficult
to make comparisons over time and across studies.
In a recent study [8], we evaluated data related to the
overall population of HIV-infected individuals who
entered care in Brazil between 2003 and 2006, estimating
the proportion of individuals entering late into care and
the impact that this has on the rates of AIDS mortality.
In the present study, we sought to analyze the demo-
graphic and epidemiological characteristics related to late
entry, estimating the absolute and relative risk, which we
calculated for that population as a whole and for differ-
ent social segments, using various clinical and immuno-
logical parameters. We have also analyzed the
proportional contribution of different social segments to
the total number of individuals entering late into HIV
care in Brazil.
Methods
To analyze the general population of HIV-infected indi-
viduals (over 15 years of age) who entered into care at
public health care facilities in Brazil between 2003 and
2006, we obtained data from the information systems of
the Brazilian National Ministry of Health. Specifically,
we obtained data from the following: the Sistema de
Controle de Exames Laboratoriais da Rede Nacional de
Contagem de Linfócitos CD4+/CD8+ e Carga Viral
(SISCEL, Brazilian National CD4+/CD8+ T Lymphocyte
Count and Viral Load Network Laboratory Test Control
System) database—for the initial CD4+ T-cell counts (the
national guidelines in Brazil state that an initial CD4+ T-
cell count must be obtained at time of entry into HIV
care); the Sistema de Informação de Agravos de Notifica-
ção (SINAN, Disease Notification Information System)—
for information on the occurrence of AIDS-related
diseases; the Sistema de Informação sobre Mortalidade
(SIM, Mortality Information System)—for information
on AIDS-related deaths (from death certificates); and the
Departamento de Informática do Sistema Único de
Saúde (DATASUS, Unified Health Care System Depart-
ment of Information Technology)—for electronic records
of treatment provided via the public health care system
and contextual information on municipalities. The cover-
age of these systems ranges from 62.3% (SINAN) to 83%
(SIM/SISCEL), as described in our earlier study [8], in
which we also addressed the completeness of the data
contained in the various databases.
To determine whether the databases employed
included information on the maximum number of HIV-
infected individuals entering into clinical treatment
during the period under study, the SISCEL, SINAN, and
SIM data were cross-referenced, by probabilistic record
linkage, and the duplicate entries generated thereby were
excluded [35]. The process of including cases in the
study was described with a specific algorithm [8]. Cases
in which data related to entry into care or mortality were
incongruent were excluded from the analysis, as were
those in which the initial CD4+ T-cell count was delayed
by more than six months, which would have misrepre-
sented the initial immunological status.
A case of late entry into HIV care was typically defined
as one in which HIV infection was diagnosed at death,
one in which HIV infection was diagnosed after the con-
dition of the patient had already been aggravated by
AIDS-related diseases, or one in which the CD4+ T-cell
count was ≤ 200 cells/mm3 at the time of diagnosis.
Those were the standard criteria. In addition, we consid-
ered an extended set of criteria, in which the first two
criteria were the same but the initial CD4+ T-cell count
was ≤ 350 cells/mm3, as well as a stricter set, in which
the first two criteria were the same but the initial CD4+
T-cell count was ≤ 100 cells/mm3. A case of HIV diag-
nosed at death was defined as a case in which the
diagnosis was made within 20 days before death. The
date of entry into care was defined as that of the earliest
record found in any of the data sources. Data related to
sex, age, and place of residence were collated into an
analysis database, with the following hierarchy: SINAN,
SIM, then SISCEL. The category of HIV transmission
was obtained exclusively for AIDS cases reported to
SINAN, because that information is not available in any
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of the other databases. We also analyzed contextual
information (geopolitical region, HIV testing rate, and
municipal population size), which were obtained from
DATASUS.
Data were stratified by geopolitical region, because
there are major differences among those regions in terms
of human development, health care access, and trends in
the AIDS epidemic. It has been shown that, in the north-
ern and northeastern regions of Brazil, in comparison
with the other regions of the country, there is a tendency
toward an increase in the incidence of AIDS, the lowest
per capita rates of medical visits, and the lowest per
capita gross domestic product (GDP) [36].
The rate of HIV testing was assessed at the municipal
level as the number of enzyme-linked immunosorbent
assay and rapid tests performed at public health care fa-
cilities per thousand population in 2008. Based on these
data, the HIV testing rate was categorized as follows: low
(≤ 1 HIV test/1,000 population); medium (between 1.01
and 10 HIV tests/1,000 population); or high (> 10 HIV
tests/1,000 population). The municipalities were categor-
ized by population: < 100,000 inhabitants; 100,000-
499,999 inhabitants; or ≥ 500,000 inhabitants.
Five categories of HIV transmission were considered:
through exclusively female-to-male sexual contact (in
heterosexual men); through exclusively male-to-female
sexual contact (in heterosexual women); through male-
to-male or male-to-female sexual contact (in homosex-
ual/bisexual men); through injection drug use; and
through transfusion of blood or blood products. Indivi-
duals fitting more than one category of transmission
were classified using the following hierarchy: recipients
of blood transfusions; injection drug users; homosexual/
bisexual males; heterosexual individuals (males or
females); and users of blood products.
The study protocol was approved by the Research
Ethics Committee of the São Paulo State STD and AIDS
Referral and Training Center, located in the city of São
Paulo, Brazil. Because patient data were collected from
the Brazilian Ministry of Health (NMH) national infor-
mation systems and analyzed anonymously after the
systems had been cross-referenced, informed consent
was not necessary.
Data analysis
The proportion and population rates of late entry into
HIV care were estimated for the standard, extended, and
strict definitions. The distribution of those rates was
examined by sex, age bracket, geopolitical region, and
HIV testing rate. Population rates (per 100,000 popula-
tion) were calculated on an annual basis, the denomin-
ator being the adult population at risk of late entry into
HIV care. Individuals already under care at the beginning
of a given year, and those in whom HIV had been
diagnosed in a timely manner during that year, were not
included in the annual denominator. The averages for
the study period were used in the analyses.
Poisson regression with a log-link function was used in
order to assess effect as risk ratios (RR) and the respect-
ive 95% confidence intervals (95% CIs), using the stand-
ard late entry criteria as the reference. Individual and
contextual variables with a p< 0.05 were included in the
model, whereas those with a p< 0.10 were excluded. The
category of HIV transmission was analyzed with a separate
Poisson regression model.
The impact of the changes in the scenario resulting
from the application of the three different sets of criteria
(standard, strict and extended) was examined by deter-
mining the differences in magnitude of the proportions
and in the profile (demographic and epidemiological
characteristics) of the individuals included under each
set of criteria.
Results
We identified 115,369 HIV-infected individuals who
entered into care in Brazil between 2003 and 2006. Of
those individuals, 56.3% were male, 66.0% were between
30 and 59 years of age, and 50.7% resided in the south-
eastern region of the country (Table 1). The annual num-
ber of new cases ranged from 24,487 (in 2003) to 31,941
(in 2005), and the annual average number of new
patients for the entire period was 28,842.
We excluded 18,638 (13.9%) cases in which the initial
CD4+ T-cell count was obtained six months or more
after entry into care, as well as 42 (0.03%) cases in which
the information related to the date of entry into care was
inconsistent. The demographic characteristics of the
excluded cases were similar to those of the cases
included in the analysis [8].
Proportion and relative risk of late entry into HIV care
As can be seen in Table 1, the overall proportion of late
entry into HIV care, according to the standard criterion,
was 43.6% (50,358 individuals) between 2003 and 2006.
We detected a slight, but statistically significant, decrease
between the first and last years of the period studied
(from 43.5% to 41.6%, p< 0.001).
Table 1 also shows that the relative risk of late entry
into HIV care was highest for the ≥ 60 year age bracket
(RR: 1.91, 95% CI: 1.85-1.98); for the northern and north-
eastern regions (RR: 1.33, 95% CI: 1.29-1.37 and RR: 1.19,
95% CI: 1.16-1.21, respectively); and for males (RR: 1.33,
95% CI: 1.31-1.35). At the municipal level, lesser, but
statistically significant, effects were observed for low HIV
testing rate (RR: 1.09, 95% CI: 1.06-1.11) and having≤
100,000 inhabitants (RR: 1.08, 95% CI: 1.06-1.10).
Information on the HIV transmission category was
available for 37,391 cases during the period under study.
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Of those, 41.9% were in heterosexual women, 30.7% were
in heterosexual men, 19.1% were in homosexual/bisexual
men, 8.0% were in injection drug users, and 0.3% were in
individuals who had received transfusions of blood or
blood products (Table 1). The highest risk ratios were
found for injection drug users (RR=1.18, 95% CI: 1.15-
1.22) and heterosexual men (RR=1.17, 95% CI: 1.15-1.19).
Marginal risk ratios were observed for being a homosex-
ual/bisexual men (RR=1.04; 95% CI: 1.02-1.07) and for
having received a blood transfusion (RR=1.15, 95% CI:
1.01-1.32).
As a corollary of the associations observed, the strati-
fied analysis of the proportion of late entry into HIV care
showed marked variation depending on the social seg-
ment analyzed (Table 2). The lowest proportion (about
half of the national average) was among women in the
15–29 year age bracket residing in the southern or
southeastern region of the country. Among such women,
the proportions were 20.2% for those residing in the
southern region and 22.2% for those residing in the
southeastern region. For individuals (of either sex) in
the ≥ 60 year age bracket and residing in the northern,
northeastern, and central-west regions of the country,
the proportion was above 60%.
Population rate of late entry into HIV care
The average population rate of late entry into HIV care
observed for Brazil as a whole was 9.9 cases/100,000
population (Table 3). Regardless of sex and geopolitical
region of residence, the average population rate was
Table 1 Proportion of late entry into HIV care, as defined by the standard criterion, with adjusted risk ratios. Brazil
(2003–2006)
Characteristic N % Proportion
of late entry
Risk ratio Adjusted
risk ratio
95% confidence
interval
p
Min Max
Brazil 115,369 100 43.6 - - - - -
Geopolitical region South 22,229 19.3 40.8 1 1 - -
North 6,270 5.4 53.4 1.31 1.33 1.29 1.37 < 0.001
Northeast 17,448 15.1 48.1 1.18 1.19 1.16 1.21 < 0.001
Central-West 7,997 6.9 47.1 1.15 1.16 1.13 1.20 < 0.001
Southeast 58,499 50.7 43.1 1.06 1.05 1.03 1.07 < 0.001
No data 2,926 2.5
Size of municipality
(number of inhabitants)
≥ 500,000 46,835 40.6 42.6 1 1 - -
100,000-499,999 33,339 28.9 43.0 1.01* 1.04 1.02 1.06 < 0.001
< 100,000 30,429 26.4 46.3 1.09 1.08 1.06 1.10 < 0.001
No data 4,766 4.1
HIV testing rate† High 89,550 77.6 42.7 1 1 - -
Medium 5,063 4.4 46.8 1.10 1.06 1.03 1.10 <0.001
Low 15,990 13.9 48.5 1.14 1.09 1.06 1.11 < 0.001
No data{ 4,766 4.1 1
Sex Female 50,354 43.6 35.7 1 - -
Male 64,932 56.3 49.8 1.40 1.33 1.31 1.35 < 0.001
No data 83 0.1
Age bracket 15-29 years 36,201 31.4 30 1 1 - -
30-59 years 76,134 66 49.5 1.65 1.60 1.58 1.63 < 0.001
≥ 60 years 3,034 2.6 59.3 1.98 1.91 1.85 1.98 < 0.001
HIV transmission
category}
Heterosexual women 15,665 41.9 - 1 1 - -
Injection drug user 2,997 8.0 - 1.18 1.18 1.15 1.22 < 0.001
Heterosexual men 11,467 30.7 - 1.21 1.17 1.15 1.19 < 0.001
Blood transfusion 107 0.3 - 1.16 1.15 1.01 1.32 0.039
Homosexual/bisexual men 7,155 19.1 - 1.06 1.04 1.02 1.07 < 0.001
*Not significant; †High => 10 tests/1,000 population, Medium= from 1.01 to 10 tests/1,000 population, Low=≤ 1 test/1,000 population; {No information available
on city of residence; }The categories of transmission were analyzed with a separate Poisson regression model, including the 37,391 individuals for whom
information on transmission category was available. Control of confounding variables = region, HIV testing rate, and age. Population size was disregarded as a
misleading variable as it did not show statistical significance in this regression model.
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found to be highest among individuals in the 30–59 year
age bracket (15.5 cases/100,000 population), in which it
was 5.3 times higher than was that found for those in
the ≥ 60 year age bracket (2.9/100,000 population).
The average population rates of late entry into HIV
care tended to rise in parallel with regional increases in
per capita GDP and in parallel with regional decreases in
the incidence of AIDS. Consequently, the average rate
was highest in the southern region (11.8/100,000 popula-
tion) and lowest in the northeastern region (6.2/100,000
population.
The population rate of late entry into HIV care tended
to decrease in parallel with that of HIV testing rates.
This tendency was observed systematically in all of the
social segments studied. In cities, where HIV testing
rates are higher, the population rate of late entry into
HIV care (12.1/100,000 population) was 22% higher than
the national average. As a corollary of this population
rate tendency, the largest proportions of individuals
entering late into HIV care were in areas where the HIV
testing rate was highest, were in the 30–59 year age
bracket, were male, and resided in certain geopolitical
Table 2 Stratified analysis of the proportion of late entry into HIV care, as defined by standard and extended criteria,
and percentage increase with the use of the extended criterion. Brazil (2003–2006)
Characteristic Female by age bracket Male by age bracket Total by age bracket
15 - 29 30 - 59 ≥ 60 Total 15 - 29 30 - 59 ≥ 60 Total 15 - 29 30 - 59 ≥ 60 Total
Standard criterion
Brazil 23.1 42.9 55.1 35.7 37.6 53.9 61.9 49.8 30.0 49.5 59.3 43.6
Geopolitical region
North 33.8 54.9 65.9 45.7 50.5 63.0 60.9 58.8 42.4 60.0 62.5 53.4
Northeast 28.1 47.9 62.0 40.1 45.2 57.3 63.8 54.0 36.5 53.8 63.2 48.1
Central-West 24.3 49.1 60.5 38.8 37.2 59.4 69.2 53.3 30.5 55.5 66.0 47.1
Southeast 22.2 42.2 55.3 35.9 35.1 52.5 61.9 48.5 28.6 48.4 59.3 43.1
South 20.2 38.8 50.6 31.4 36.0 54.0 62.0 49.5 26.6 47.6 57.6 40.8
HIV testing rate1
High 22.5 42.0 54.9 35.1 36.2 52.6 61.3 48.5 29.2 48.4 58.8 42.7
Medium 26.4 45.5 63.2 38.6 41.8 58.1 55.4 54.0 32.9 52.8 58.3 46.8
Low 25.3 47.3 56.2 38.7 45.5 61.3 65.5 57.2 34.1 55.4 62.4 48.5
Extended criterion
Brazil 39.4 58.5 66.8 51.5 52.4 68.1 75.6 64.1 45.6 64.3 72.2 58.6
Geopolitical region
North 55.7 74.7 81.8 66.4 67.6 78.9 76.1 75.1 61.8 77.4 77.9 71.5
Northeast 43.7 62.8 71.5 55.2 60.6 71.0 79.2 68.3 52.0 67.9 76.6 62.7
Central-West 43.0 65.0 73.7 55.9 53.7 74.2 82.7 68.6 48.2 70.8 79.4 63.2
Southeast 37.4 57.3 66.4 50.9 49.3 66.3 74.1 62.3 43.3 62.7 71.1 57.4
South 37.9 56.7 65.4 49.1 51.7 69.1 78.1 64.8 43.5 63.9 73.2 57.3
HIV testing rate*
High 39.1 58.1 67.5 51.3 51.4 67.1 75.3 63.1 45.1 63.5 72.2 58.0
Medium 42.2 61.0 73.7 54.2 56.0 72.7 66.2 68.4 48.1 67.7 68.9 61.7
Low 41.8 61.9 66.4 53.9 60.5 74.4 80.0 70.8 49.9 69.1 75.5 62.9
Percentage increase with extended criterion
Brazil 70.6 36.6 21.2 44.4 39.4 26.3 22.0 28.7 52.0 29.9 21.8 34.4
Geopolitical region
North 65.1 36.1 24.1 45.3 33.9 25.2 25.0 27.7 45.8 28.8 24.6 33.9
Northeast 55.5 31.1 15.3 37.7 34.1 23.9 24.3 26.3 42.5 26.4 21.2 30.4
Central-West 77.4 32.4 21.8 44.1 44.4 25.1 19.5 28.7 58.0 27.6 20.3 34.2
Southeast 68.5 35.5 20.1 41.8 40.5 26.3 19.7 28.7 51.4 29.5 19.9 33.2
South 87.6 45.9 29.1 56.4 43.6 28.0 26.0 30.9 63.2 34.2 27.1 40.2
*High => 10 tests/1,000 population; Medium= from 1.01 to 10 tests/1,000 population; Low=≤ 1 test/1,000 population.
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regions (those with a higher GDP and a decreasing inci-
dence of AIDS), accounting for 79.1%, 74.9%, 64.2%, and
50.6%, respectively, of all cases of late entry into HIV care
between 2003 and 2006 (Figure 1).
Stricter and extended criteria
When late entry into HIV care was defined according to
the stricter criterion (Table 4), there were 34,088 cases
(29.5% of all reported cases). Of those, 19,631 (17.0% of all
Table 3 Population rates* of late entry into HIV care (100,000 population), as defined by standard and extended
criteria. Brazil (2003–2006)
Characteristics Female by age bracket Male by age bracket Total by age bracket
15 to 29 30 to 59 ≥ 60 Total 15 to 29 30 to 59 ≥ 60 Total 15 to 29 30 to 59 ≥ 60 Total
Standard criterion
Brazil 4.4 10.5 1.8 7.0 6.5 21.3 4.1 13.3 5.3 15.5 2.9 9.9
Geopolitical region
North 4.5 9.9 1.8 6.6 7.1 18.5 3.5 11.8 5.8 14.3 2.7 9.2
Northeast 2.8 6.5 0.9 4.2 4.5 13.9 2.2 8.3 3.7 10.0 1.5 6.2
Central-West 4.6 10.6 2.7 7.3 6.6 22.1 5.6 13.9 5.6 16.3 4.1 10.6
Southeast 4.3 11.7 2.2 7.7 6.8 23.5 4.9 14.8 5.5 17.4 3.4 11.1
South 6.4 11.6 2.2 8.4 7.7 23.1 5.2 15.3 7.0 17.2 3.5 11.8
HIV testing rate}
High 5.2 12.4 2.3 8.3 8.1 26.2 5.5 16.7 6.5 18.7 3.8 12.1
Medium 4.4 9.9 1.7 6.7 5.2 18.0 2.7 11.0 4.6 13.8 1.9 8.6
Low 2.3 5.3 0.7 3.5 3.1 9.6 1.7 5.9 2.6 7.4 1.2 4.6
Extended criterion
Brazil 7.2 14.1 2.3 9.9 8.8 26.4 5.1 16.8 8.0 20.0 3.6 13.2
Geopolitical region
North 7.4 13.5 2.3 9.6 9.4 23.2 4.4 15.0 8.4 18.5 3.4 12.3
Northeast 4.4 8.5 1.1 5.8 6.0 17.2 2.7 10.5 5.2 12.6 1.8 8.1
Central-West 8.1 14.0 3.3 10.5 9.5 27.7 6.7 17.9 8.8 20.8 5.0 14.2
Southeast 7.2 15.9 2.6 10.9 9.5 29.6 5.9 19.1 8.4 22.5 4.0 14.8
South 11.9 16.9 2.8 13.2 11.1 29.6 6.6 20.0 11.5 23.1 4.5 16.5
HIV testing rate}
High 8.7 16.8 3.0 11.9 11.3 33.0 7.0 21.4 10.0 24.5 4.7 16.5
Medium 6.8 13.4 1.6 9.3 6.6 22.2 2.9 13.6 6.7 17.7 2.2 11.4
Low 3.7 7.0 0.9 4.8 4.0 11.4 2.2 7.1 3.8 9.2 1.5 6.0
*Average for 2003 to 2006.
}High => 10 tests/1,000 population; Medium= from 1.01 to 10 tests/1,000 population; Low=≤ 1 test/1,000 population.
Figure 1 Proportional distribution of the total numbers of cases of late entry into HIV care, as defined by the standard criterion. Brazil
(2003–2006).
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reported cases) had met the criterion on the basis of the
initial CD4+ T-cell count, and 14,457 (12.5% of all reported
cases) were cases of diagnosis at death. Individuals in
whom late entry was classified according to the stricter
criterion accounted for 67.7% of those in whom it was
classified according to the standard criterion. Among those
in whom late entry was classified according to the stricter
criterion, there was a predominance of men, individuals in
the≥ 60 year age bracket, and individuals residing in
certain geopolitical regions (those with a lower GDP and
an increasing incidence of AIDS).
When late entry into HIV care was defined according to
the extended criterion (Table 2), there were 67,615 cases
(58.6% of all reported cases). The proportions were highest
among residents of the geopolitical regions with a lower
GDP and an increasing incidence of AIDS, especially
among men in the 30–59 year age bracket, as well as
among men and women in the≥ 60 year age bracket. In
those social segments, the proportions were approximately
80% when the extended criterion was applied.
In comparison with late entry classified according to
the standard criterion, the use of the extended criterion
resulted in the inclusion of an additional 17,257 indivi-
duals (a 34.4% increase). The largest proportional in-
crease (of over 70%) was observed among the population
segments with the lowest proportion of late entry into
HIV care when the standard criterion was applied,
among which there was a predominance of women in
the 15–29 year age bracket, especially in the geopolitical
regions with a higher GDP and a decreasing incidence of
AIDS.
When the stricter, standard, and extended criteria were
compared in terms of the relative risk, the only differences
observed were in the magnitude of the risk ratio, which
trended discretely higher for the stricter criterion and
discretely lower for the extended criterion. In addition, the
categories presenting a marginal association when the
standard criterion was applied lost their significance when
the extended criterion was applied. That was especially
true for the southeastern region, for municipalities with
100,000-499,999 inhabitants, and for being a homosexual/
bisexual man (Table 5).
Discussion
Because the Brazilian information systems provide
consistent data on cases of HIV infection, it has been
possible to increase our knowledge of aspects that are
rarely discussed in the literature. A particular concern is
the lack of information regarding late entry into HIV
care in middle-income countries. The results of the
present study show that, in Brazil, at least 2 out of every
5 HIV-infected individuals entered late into care between
2003 and 2006. Of those, approximately 70% presented
with severe clinical and immunological impairment, of
whom approximately 30% were diagnosed only at death.
In addition, the application of the extended criterion (i.
e., the inclusion of individuals with an initial CD4+ T-cell
count ≤ 350 cells/mm3) increased the number of indivi-
duals entering late into HIV care by approximately one
third. Therefore, approximately 6 out of every 10 HIV-
infected individuals who entered into care in Brazil did
so without having the opportunity to receive ART when
it would have been most effective, resulting in less
protection against new cases of infection in others and
potentially higher nationwide rates of AIDS progression
and mortality [1,2,8]. Such elevated rates could be re-
sponsible for the lack of advances in policies aimed at
combating AIDS between 2000 and 2010, a period
during which the absolute and relative numbers of AIDS
cases increased [37].
Taking as our point of reference the proportion of late
entry into HIV care when the standard criterion was
applied, we found that Brazil is in an intermediate pos-
ition in comparison with other countries. Lower propor-
tions have been reported for high-income countries and
regions, such as Northern France and Brussels (31.3% in
the 1997–2007 period) [16]; New Zealand (32.0% in the
2005–2009 period) [23]; the United Kingdom and
Ireland (33.4% in 2003) [19]; the United States (36.4% in
2005) [22]; Barcelona (38.5% in the 2001–2009 period)
[21]; and Italy (39.2% in the 1997–2000 period) [18].
However, higher proportions have been reported for low-
and middle-income countries. In a cohort study involving
36,000 patients in 12 countries [24], the collective pro-
portions were 77% for the countries in Africa, 78% for
Table 4 Proportion of late entry into HIV care, as defined by the stricter criterion. Brazil (2003–2006)
Characteristics Female by age bracket Male by age bracket Total by age bracket
15 - 29 30 - 59 ≥ 60 Total 15 - 29 30 - 59 ≥ 60 Total 15 - 29 30 - 59 ≥ 60 Total
Brazil 13.9 28.7 37.6 23.3 25.2 37.4 44.8 34.4 19.3 33.9 42.1 29.5
Geopolitical region
North 20.0 35.5 38.6 28.6 34.8 44.2 44.6 41.1 27.6 40.9 42.6 35.9
Northeast 18.6 33.7 40.9 27.7 31.8 41.6 44.2 38.8 25.1 38.6 43.0 34.1
Central-West 14.0 32.5 40.8 24.8 24.2 40.3 47.4 35.8 18.9 37.4 45.0 31.2
Southeast 12.9 28.6 39.6 23.7 23.3 36.3 47.3 33.4 18.1 33.2 44.3 29.3
South 11.7 24.3 31.2 19.2 23.1 36.3 41.0 33.0 16.4 31.3 37.2 26.4
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the countries in Asia, and 51% for the countries in South
America. Proportions higher than that observed in
Brazil have also been reported for Thailand (55% for
the 2003–2004 period) [32] and for Vietnam (58.3%
for the 2004–2005 period) [38]. In Brazil, the reported
proportion of late entry into HIV care has ranged from
42% in a nationwide study defining entry into care as the
initiation of ART [34] to 68% in a study evaluating outpati-
ents in the Brazilian state of Minas Gerais [33]. Compari-
sons across studies should be undertaken with caution,
because different researchers adopt different definitions of
late entry and evaluate different populations [31].
It is of note that we have combined a population-based
risk assessment (based on population rates of late entry
into HIV care) with a relative risk assessment (based on
proportions and risk ratios for such late entry). Using
this approach, we obtained results that differ, in many
aspects, from those reported in the literature [16,19-
23,32,38]. One such discrepancy is the fact that, when
analyzing the population-based risk (assessed by late entry
rate), we found that, for individuals in the 30–59 year age
bracket residing in geopolitical regions with a higher GDP,
a decreasing incidence of AIDS, and the highest HIV
testing rates, the risk of late entry into HIV care was 35%
higher than the national average, despite the lower relative
risk and lower proportions of late entry found for that
same group. Such individuals accounted for approximately
70% of the total number of cases of late entry in Brazil be-
tween 2003 and 2006. These results can be understood
within the context of the fact that the population-based
risk varied depending on the prevalence of HIV/AIDS
within the country. Therefore, the geopolitical regions and
social segments most affected by the epidemic [36] and in
which the number of HIV-Infected individuals was highest
tended to present the highest absolute risks and the
highest numbers of cases of late entry into care, regardless
of the proportion of late entry observed for those groups
and regions.
Table 5 Proportion of late entry into HIV care, as defined by the extended and stricter criteria, with adjusted risk
ratios. Brazil (2003–2006)
Characteristic Extended Criterion Stricter Criterion
Adjusted
risk ratio
95% Confidence
interval
p Adjusted
risk ratio
95% Confidence
interval
p
Min Max Min Max
Geopolitical Region South 1 - - - 1 - - -
North 1.26 1.23 1.28 < 0.001 1.41 1.35 1.47 < 0.001
Northeast 1.10 1.08 1.11 < 0.001 1.30 1.26 1.34 < 0.001
Central-West 1.11 1.08 1.13 < 0.001 1.20 1.14 1.24 < 0.001
Southeast 1.00 0.98 1.01 0.498 1.11 1.08 1.13 < 0.001
Size of municipality
(number of inhabitants)
≥ 500,000 1 - - - 1 - -
100,000-499,999 1.01 1.00 1.02 0.194 1.07 1.05 1.09 < 0.001
< 100,000 1.02 1.01 1.04 0.005 1.10 1.07 1.13 < 0.001
HIV testing rate† High 1 - - - 1 - - -
Medium 1.05 1.03 1.08 < 0.001 1.11 1.06 1.16 <0.001
Low 1.07 1.05 1.09 < 0.001 1.11 1.08 1.15 < 0.001
Sex Female 1 - - - 1 - - -
Male 1.20 1.19 1.21 < 0.001 1.40 1.37 1.42 < 0.001
Age 15-29 years 1 - - - 1 - - -
30-59 years 1.39 1.37 1.40 < 0.001 1.70 1.66 1.74 < 0.001
≥ 60 years 1.56 1.52 1.60 < 0.001 2.10 2.00 2.20 < 0.001
HIV Category of transmission} Heterosexual women 1 - - - 1 - - -
Injection drug user 1.07 1.05 1.09 < 0.001 1.15 1.09 1.21 < 0.001
Heterosexual man 1.08 1.07 1.09 < 0.001 1.15 1.12 1.19 < 0.001
Blood transfusion 1.11 1.03 1.19 0.004 0.96 0.73 1.27 0.793
Homosexual/bisexual male 1.01 0.99 1.02 < 0.203 1.00 0.96 1.04 < 0.001
†High => 10 tests/1,000 population; Medium= from 1.01 to 10 tests/1,000 population; Low=≤ 1 test/1,000 population. }The categories of transmission were
analyzed with a separate Poisson regression model, including the 37,391 individuals for whom information on transmission category was available. Control of
confounding variables = region, HIV testing rate, and age. Population size was disregarded as a misleading variable as it did not show statistical significance in this
regression model.
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The advantage of using a approach in which the point
of reference is the absolute risk is that it adds a public
health perspective to the knowledge gathered to date
regarding late entry into HIV care. If this new knowledge
is applied, public policies designed to promote the early
diagnosis of HIV infection will be more effective in
reducing the number of cases of late entry into care,
because they will prioritize the social segments and
geopolitical regions in which the population rates of late
entry are highest.
Analyses of relative risk (based on risk ratios) can
facilitate the identification of social segments in which
there are disproportionately large concentrations of cases
of late entry into HIV care, as well as promoting the
understanding of the factors that increase the probability
of such late entry. Using such analyses, we observed that
an increase in the proportion of late entry was independ-
ently associated with social differences (gender differences,
generational differences, differences in sexual practices,
and differences in terms of injection drug use), as well as
contextual differences (related to the level of economic
development and access to HIV testing at public health
care facilities).
Our results, in terms of the social differences, are in
agreement with those of studies conducted in other
regions of the world [16,19-23,32], which have reported
that the probability of late entry into HIV care is highest
among older individuals, men (especially heterosexual
men), and injection drug users. These findings can be
explained by the social and cultural aspects of the AIDS
epidemic [13,26] and by the barriers to health care access
[18,19,27]. Therefore, late entry into HIV care tends to
take on added importance in individuals who are not
recognized as being at risk of HIV infection or who do
not perceive themselves to be at such risk, such as older
individuals [20,21]; individuals in whom the rates of
treatment seeking are low, such as men [16,38]; and
individuals who are socially marginalized, such as
injection drug users [16,19,21]. In Brazil, this inequality
is evidenced, in part, by HIV testing rates. In a home-
based study conducted in Brazil in 2005 [39], the social
segments in which the HIV testing rate was found to be
lowest among men (28%) and among individuals ≥ 45
years of age (21%), whereas that rate was above the
national average (of 34%) among women (38%), especially
among those in the 25–34 year age bracket (60%). This is
primarily attributable to prenatal HIV testing. Among
homosexual men, the HIV testing rate was found to be
below 60% [39].
In terms of the contextual factors analyzed, we found
that a higher HIV testing rate translated to a lower
proportion of late entry. This is underscored by the fact
that, during the period evaluated, a 5% increase in the
rates of HIV testing [40] was paralleled by the 4.6%
reduction we observed in the proportion of late entry.
That same relationship has been evaluated in studies
investigating the effectiveness and cost-effectiveness of
HIV testing [15,41,42], which have also shown that an
increase in the availability of HIV testing corresponds
to a higher rate of timely diagnosis and longer life expect-
ancy of HIV-infected individuals.
The differences observed among municipalities of
different population sizes, in terms of the proportion of
late entry into HIV care, might reflect differences in the
ease of access to HIV diagnosis and treatment, which
tends to be restricted in smaller municipalities, where
there are fewer HIV testing centers, it is more difficult to
guarantee anonymity, and the social stigma associated
with AIDS is often greater.
The association found between late entry into HIV care
and geopolitical region with a lower GDP/increasing
incidence of AIDS might indicate a two-fold relationship:
a lower level of economic development creates barriers
to health care access, increasing the proportion of late
entry, which is, in turn, a major cause of the increase in
the rate of new cases of HIV infection. This possible
vicious cycle is a challenge for health care policy makers,
and the promotion of early diagnosis in such regions
might be an inflection point for improving our control of
the epidemic.
Another important aspect of the present study was the
application of three different criterion for defining late
entry into HIV care. This approach allowed us to depict
entry into care at the various stages in the evolution of
HIV infection. Some initiatives have attempted to
achieve a consensus regarding late entry into HIV care,
with the objectives of increasing comparability across
studies and implementing strategies of epidemiological
surveillance of such late entry. In one such initiative
[31], “late presentation” and “presentation with advanced
HIV disease” were defined in a manner similar to that of
the extended and standard criteria, respectively,
employed in the present study. One advantage of using
multiple criteria to define late entry was that it allowed
us to characterize the contingent of HIV-infected indivi-
duals who are more likely to die because of such late
entry, as occurred in nearly a third of those who were in
the advanced stages of HIV infection upon entry into
care. In addition, using multiple sets of criteria, we were
able to highlight the potential lost opportunities to pre-
vent new infections in others and to slow the advance of
the AIDS epidemic, through the timely initiation of ART
[1,2], as occurred in nearly a two thirds of all HIV-
infected individuals who began to receive ART later than
recommended. If we further extended the criterion to in-
clude individuals with CD4+ T-cell counts of 350–500
cells/mm3, the magnitude of these losses would be even
greater, because the use of ART at that stage of infection
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could reduce sexual HIV transmission by 90% and the
incidence of AIDS-related diseases by 40% [2].
It is noteworthy that we found not substantial statis-
tical differences between the use of each of these distinct
criteria in terms of the individual and contextual factors
that led to an increase in the proportion of late entry,
whether analyzed on the basis of relative risk or on the
basis of population rates. Therefore, it seems unneces-
sary to make major changes in the policies guidelines
designed to promote timely access to the diagnosis and
treatment of HIV infection specifically for individuals at
a given clinical stage of infection.
The results we obtained by applying different sets of
criteria for defining late entry in HIV care provide evi-
dence of the need to establish precise parameters for ac-
cess to ART, based on the stage of the infection,
especially in countries where there are insufficient sup-
plies of antiretroviral drugs, in order to achieve a balance
between the benefits of early initiation of ART in asymp-
tomatic individuals [2,43,44] and the logic of prioritizing
the treatment of AIDS patients in whom the risk of
death is elevated because of greater clinical and im-
munological severity [4,6,8]. Although the ability of ART
to reduce the transmission of HIV is well known [1,2], it
should be borne in mind that the principal objective of
ART is to improve the quality of life of HIV-infected
individuals. In addition, there is no consistent evidence
that the HIV/AIDS epidemic can be controlled through
biomedical interventions [45].
The results obtained in the present study should be
interpreted within the limits of its data and analysis,
which were described in a previous study [8], in which
we also analyzed the potential effects of excluding
individuals in whom CD4+ T-cell counts were not
obtained within the first six months after diagnosis. One
significant limitation of the present study is the use of
secondary data, which should not be taken at face value.
The categories of HIV transmission require cautious
interpretation, because we analyzed only the patients
who progressed to AIDS, who could have characteristics
that are different from those of individuals in the earlier
stages of the disease. The purpose of including trans-
mission categories here was to compensate for the lack
of such information in other studies, especially in those
conducted in low- or middle-income countries. Never-
theless, this study allowed us a glimpse into the com-
plexity of late entry into HIV care, considering different
criteria of classification and risk assessment. The results
indicate a need to strengthen policies for timely diagno-
sis of HIV infection and alert us to the fact that,
without changes in the proportion of late entry into
HIV care, the epidemic is likely to be aggravated in less
developed regions and in those with limited access to
health care.
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